Prestige Consumer Healthcare, Inc. (PBH)
46.19
+0.87
(+1.92%)
USD |
NYSE |
Nov 13, 16:00
46.16
-0.04
(-0.08%)
After-Hours: 19:59
Prestige Consumer Healthcare Market Cap : 2.189B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.189B |
| November 12, 2026 | 2.148B |
| November 11, 2026 | 2.094B |
| November 10, 2026 | 2.131B |
| November 09, 2026 | 2.070B |
| November 06, 2026 | 2.037B |
| November 05, 2026 | 2.101B |
| November 04, 2026 | 2.525B |
| November 03, 2026 | 2.348B |
| November 02, 2026 | 2.356B |
| October 30, 2026 | 2.324B |
| October 29, 2026 | 2.309B |
| October 28, 2026 | 2.264B |
| October 27, 2026 | 2.245B |
| October 26, 2026 | 2.281B |
| October 23, 2026 | 2.264B |
| October 22, 2026 | 2.343B |
| October 21, 2026 | 2.270B |
| October 20, 2026 | 2.338B |
| October 19, 2026 | 2.355B |
| October 16, 2026 | 2.365B |
| October 15, 2026 | 2.331B |
| October 14, 2026 | 2.293B |
| October 13, 2026 | 2.298B |
| October 12, 2026 | 2.321B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.285B |
| October 08, 2026 | 2.268B |
| October 07, 2026 | 2.253B |
| October 06, 2026 | 2.200B |
| October 05, 2026 | 2.160B |
| October 02, 2026 | 2.144B |
| October 01, 2026 | 2.121B |
| September 30, 2026 | 2.173B |
| September 29, 2026 | 2.214B |
| September 28, 2026 | 2.223B |
| September 25, 2026 | 2.208B |
| September 24, 2026 | 2.163B |
| September 23, 2026 | 2.175B |
| September 22, 2026 | 2.261B |
| September 21, 2026 | 2.217B |
| September 18, 2026 | 2.130B |
| September 17, 2026 | 2.201B |
| September 16, 2026 | 2.220B |
| September 15, 2026 | 2.211B |
| September 14, 2026 | 2.256B |
| September 11, 2026 | 2.224B |
| September 10, 2026 | 2.243B |
| September 09, 2026 | 2.307B |
| September 08, 2026 | 2.359B |
| September 04, 2026 | 2.476B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Supernus Pharmaceuticals, Inc. | 1.731B |
| Phibro Animal Health Corp. | 1.460B |
| Structure Therapeutics, Inc. | 1.427B |
| ANI Pharmaceuticals, Inc. | 1.636B |
| Corcept Therapeutics, Inc. | 7.977B |
Market Cap Related Metrics
| PE Ratio | 14.23 |
| PS Ratio | 1.890 |
| Price to Book Value | 1.126 |
| Price to Free Cash Flow | 10.29 |
| Price | 46.19 |
| Earnings Yield | 7.03% |
| Operating PE Ratio | 7.572 |
| Normalized PE Ratio | 14.14 |